The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers

被引:10
|
作者
Benko, Tamas [1 ]
Gallinat, Anja [1 ]
Minor, Thomas [1 ]
Saner, Fuat H. [1 ]
Sotiropoulos, Georgios C. [1 ]
Paul, Andreas [1 ]
Hoyer, Dieter P. [1 ]
机构
[1] Univ Essen Duisburg, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
关键词
extended criteria donor; liver graft dysfunction; postoperative Model for End stage Liver Disease; risk assessment; EARLY ALLOGRAFT DYSFUNCTION; SINGLE-CENTER EXPERIENCE; PRIMARY NONFUNCTION; GRAFT FUNCTION; MELD; RETRANSPLANTATION; PRESERVATION; DEFINITION; ALLOCATION; RECIPIENTS;
D O I
10.1097/MEG.0000000000000851
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Recently, the postoperative Model for End stage Liver Disease score (POPMELD) was suggested as a definition of postoperative graft dysfunction and a predictor of outcome after liver transplantation (LT). Aim The aim of the present study was to validate this concept in the context of extended criteria donor (ECD) organs. Patients and methods Single-center prospectively collected data (OPAL study/01/11-12/13) of 116 ECD LTs were utilized. For each recipient, the Model for End stage Liver Disease (MELD) score was calculated for 7 postoperative days (PODs). The ability of international normalized ratio, bilirubin, aspartate aminotransferase, Donor Risk Index, a recent definition of early allograft dysfunction, and the POPMELD was compared to predict 90-day graft loss. Predictive abilities were compared by receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values. Results The median Donor Risk Index was 1.8. In all, 60.3% of recipients were men [ median age of 54 (23-68) years]. The median POD1-7 peak-aspartate aminotransferase value was 1052 (194-17 577) U/l. The rate of early allograft dysfunction was 22.4%. The 90-day graft survival was 89.7%. Out of possible predictors of the 90-day graft loss MELD on POD5 was the best predictor of outcome (area under the curve = 0.84). A MELD score of 16 or more on POD5 predicted the 90-day graft loss with a specificity of 80.8%, a sensitivity of 81.8%, and a positive and negative predictive value of 31 and 97.7%. Conclusion A MELD score of 16 or more on POD5 is an excellent predictor of outcome in ECD donor LT. Routine evaluation of POPMELD scores might support clinical decision-making and should be reported routinely in clinical trials. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 50 条
  • [1] Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?
    Li, C.
    Wen, T.
    Yan, L.
    Li, B.
    Wang, W.
    Xu, M.
    Yang, J.
    Wei, Y.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3620 - 3623
  • [2] Pretransplant Model for End-Stage Liver Disease Score as a Predictor of Postoperative Complications After Liver Transplantation
    Siniscalchi, A.
    Cucchetti, A.
    Toccaceli, L.
    Spiritoso, R.
    Tommasoni, E.
    Spedicato, S.
    Dante, A.
    Riganello, L.
    Zanoni, A.
    Cimatti, M.
    Pierucci, E.
    Bernardi, E.
    Miklosova, Z.
    Pinna, A. D.
    Faenza, S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (04) : 1240 - 1242
  • [3] Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome
    Khandoga, Andrej
    Iskandarov, Emil
    Angele, Martin
    Gerbes, Alexander
    Frey, Lorenz
    Agayev, Boeyuekkishi
    Jauch, Karl-Walter
    Werner, Jens
    Guba, Markus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 153 - 158
  • [4] Predicting early allograft failure and mortality after liver transplantation: The role of the postoperative model for end-stage liver disease score
    Wagener, Gebhard
    Raffel, Brian
    Young, Andrew T.
    Minhaz, Moury
    Emond, Jean
    LIVER TRANSPLANTATION, 2013, 19 (05) : 534 - 542
  • [5] Assessment of short-term survival after liver transplant by the model for end-stage liver disease
    Buenadicha, AL
    Martín, LG
    Martín, EE
    Pajares, A
    Pérez, AM
    Seral, CC
    Marugán, RB
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3881 - 3883
  • [6] Impact of the Model for End-Stage Liver Disease Score on Mortality After Liver Transplantation
    Cabeza de Vaca, V. G.
    Bellido, C. B.
    Martinez, J. N. A.
    Artacho, G. S.
    Gomez, L. M. M.
    Diaz-Canedo, J. S.
    Ruiz, F. J. P.
    Bravo, M. A. G.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 2069 - 2070
  • [7] Model for End-Stage Liver Disease score versus Maddrey Discriminant Function score in assessing short-term outcome in alcoholic hepatitis
    Kadian, Monil
    Kakkar, Rajesh
    Dhar, Minakshi
    Kaushik, Rajeev Mohan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 581 - 588
  • [8] The impact of obesity on postoperative complications and short-term survival after liver transplantation
    Tejedor-Tejada, Javier
    Garcia-Pajares, Felix
    Safadi, Rifaat
    Mauriz-Barreiro, Violeta
    Molina, Esther
    Juan-Casamayor, Laura
    Fernandez-Prada, Samuel
    Helal, Abdelaleem
    Fuentes-Valenzuela, Esteban
    Alonso-Martin, Carmen
    Almohalla-Alvarez, Carolina
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (07) : 782 - 789
  • [9] LIVING DONOR LIVER TRANSPLANTATION IN HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE
    Dayangac, M.
    Akyildiz, M.
    Gungor, G.
    Erdogan, Y.
    Tokat, Y.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 23
  • [10] Prediction of Graft Dysfunction Based on Extended Criteria Donors in the Model for End-Stage Liver Disease Score Era
    Briceno, Javier
    Ciria, Ruben
    de la Mata, Manuel
    Rufian, Sebastian
    Lopez-Cillero, Pedro
    TRANSPLANTATION, 2010, 90 (05) : 530 - 539